LONDON and BAD HOMBURG, Germany, Dec. 10, 2024 (GLOBE NEWSWIRE) -- Ori Biotech Ltd. (Ori), a leader in cell and gene therapy (CGT) manufacturing technology, and Fresenius Kabi, an operating company of ...
Cellular Origins and Fresenius Kabi, an operating company of Fresenius, announce today they have signed a development agreement that leverages each company’s expertise in cell and gene therapies (CGTs ...
Cellular Origins announced they have successfully completed the first phase of their collaboration with Fresenius Kabi designed to help scale the manufacturing of cell and gene therapies using ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results